Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast CancerLuigi Tarantini, Pompilio Faggiano, Giovanni Cioffi et al.|Journal of Cardiac Failure|2011Cited by 116
Administration of Angiotensin-Converting Enzyme Inhibitors and <i>β</i>-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?Stefano Oliva, Giovanni Cioffi, Silvia Frattini et al.|The Oncologist|2012Cited by 49
Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancerGiulia Russo, Luigi Tarantini, Giovanni Cioffi et al.|Journal of Cardiovascular Medicine|2014Cited by 27
In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and TherapyVincenzo Quagliariello, Nicola Maurea, Christian Cadeddu Dessalvi et al.|Cancers|2025Cited by 25
SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-OncologyAlessandra Greco, Fabrizio Oliva, Maria Laura Canale et al.|International Journal of Molecular Sciences|2025Cited by 20